Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Not Confirmed
Not Confirmed
12-15 February, 2025
Asia Pharma ExpoAsia Pharma Expo
Not Confirmed
Not Confirmed
12-14 February, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Industry Trade Show
Not Confirmed
12-15 February, 2025
Asia Pharma ExpoAsia Pharma Expo
Industry Trade Show
Not Confirmed
12-14 February, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-okays-50-new-drugs-in-2024-bms-cobenfy-lilly-s-kisunla-lead-pack-of-breakthrough-therapies
22 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/abbott-reports-fourth-quarter-and-full-year-2024-results-issues-2025-financial-outlook-302357321.html
02 Jan 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/medtech/abbott-dexcom-agree-10-year-truce-over-diabetes-sensor-patent-litigation
02 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/abbott-hosts-conference-call-for-fourth-quarter-earnings-302337311.html
17 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/abbott-announces-first-in-world-leadless-pacing-procedures-in-the-left-bundle-branch-area-of-the-heart-302333484.html
13 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/abbott-increases-quarterly-dividend-for-53rd-consecutive-year-302331449.html
11 Dec 2024
// RAPS
https://www.raps.org/news-and-articles/news-articles/2024/12/advamed,-abbott-ask-fda-to-prioritize-cybersecurit
Excipients
Inspections and registrations